Karen Hoffmann, MD
Otolaryngology · Atlanta, GANPI 1629072426
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $185,192 of the $222,567 with a category attached, or 83.2%. 33 manufacturers reported payments, led by Medical Device Business Services, Inc. at 52.6% of the total. Reporting peaked in 2021 at $77,506 and has fallen 80.7% since, to $14,938 in 2025. Among otolaryngology clinicians in GA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 438 payments — averaging $508.14 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medical Device Business Services, Inc.$117K
- Acclarent, Inc$85K
- Medtronic$9K
- Aerin Medical Inc.$4K
- Integra Lifesciences Corporation$4K
- Regeneron Healthcare Solutions, Inc.$662
- plus $3K from 27 others
Across 8 payments — averaging $5585.13 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Aerin Medical Inc.$45K
What the payments were for
- Consulting fees$185,19283%
- Speaking & faculty fees$8,4004%
- Travel & lodging$19,0149%
- Food & beverage$9,9204%
- Education$340%
- Gifts$70%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medical Device Business Services, Inc. | 131 | $116,989 |
| Acclarent, Inc | 133 | $84,855 |
| Medtronic(2 entities) | 11 | $9,472 |
| Aerin Medical Inc. | 24 | $3,673 |
| Integra Lifesciences Corporation | 16 | $3,661 |
| Regeneron Healthcare Solutions, Inc. | 24 | $662 |
| Biosense Webster, Inc. | 2 | $638 |
| Spirair, Inc. | 1 | $423 |
| Sanofi | 14 | $311 |
| GSK | 22 | $277 |
| Optinose US, Inc. | 9 | $251 |
| Intersect ENT, Inc. | 10 | $218 |
| Neurent Medical Limited | 2 | $151 |
| Stryker | 4 | $139 |
| AstraZeneca | 1 | $135 |
| Hikma Pharmaceuticals USA | 7 | $103 |
| ARS Pharmaceuticals Operations, Inc. | 1 | $101 |
| Kaleo, Inc. | 6 | $96 |
| Amgen | 4 | $83 |
| Acelrx Pharmaceuticals, Inc. | 2 | $47 |
| Alk-abello, Inc | 2 | $43 |
| Cochlear Americas | 1 | $36 |
| AbbVie | 1 | $31 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $24 |
| Merck | 1 | $21 |
| Novartis | 1 | $18 |
| Smith+Nephew | 1 | $17 |
| Johnson & Johnson | 1 | $17 |
| 3nt Medical | 1 | $17 |
| Phadia US Inc. | 1 | $15 |
| Aytu Biopharma, Inc. | 1 | $15 |
| Olympus America Inc. | 1 | $14 |
| KARL Storz Endoscopy-america | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- ACCLARENT Balloon Inflation Device$56,819
- TruDi Nav Suction$24,706
- ACCLARENT AERA EUSTACHIAN TUBE BALLOON DILATION SYSTEM$13,750
- SpinPlus Navigation$11,945
- TruDi$11,945
- HYDRODEBRIDER$9,236
- ACCLARENT NAVWIRE Sinus Navigation Guidewire$6,703
- Acclarent ENT Navigation System$5,400
- INTEGRA$4,880
- Acclarent Aera$3,665
- VIVAER STYLUS$2,515
- TruDi Nav Cable$1,751
- TruDi Navigation System$1,200
- RHINAER STYLUS$1,139
- SeptAlign$847
- TURBALIGN$847
- Acclarent Navwire$702
- INTEGRA DERMAL REGENERATION TEMPLATE$493
- PRIMATRIX$493
- GENTRIX$282
How this compares
$222,567 in reported general payments places this provider in the 95th percentile of 308 otolaryngology providers in Georgia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Azelastine Hcl | 475 | $13,144 |
| Ipratropium Bromide | 198 | $6,329 |
| Fluticasone Propionate | 335 | $4,410 |
| Epinephrine | 13 | $2,408 |
| Fluocinolone Acetonide Oil | 20 | $873 |
| Doxycycline Hyclate | 35 | $426 |
| Cimetidine | 13 | $372 |
| Prednisone | 68 | $288 |
| Mupirocin | 50 | $246 |
| Nortriptyline Hcl | 11 | $244 |
| Omeprazole | 51 | $199 |
| Triamterene-HydrochlorothiazidTriamterene/Hydrochlorothiazid | 19 | $196 |
| Meclizine Hcl | 16 | $129 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 12 | $101 |
| Meloxicam | 14 | $27 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Hikma Pharmaceuticals USAEpinephrine | $103 | $2,40813 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 308 otolaryngology providers in Georgia.
Other otolaryngology in Atlanta
- Jose StolovitzkyAtlanta$81K
- Daniel CarothersAtlanta$8K
- Adam KleinAtlanta$8K
- Pradeep SinhaAtlanta$7K
- Kingsley ChinAtlanta$6K
- John SongAtlanta$6K
- James HamiltonAtlanta$5K
- Elizabeth ShawAtlanta$5K
- Michael KoriwchakAtlanta$5K
- Gamwell RogersAtlanta$5K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.